London, Jan 3 (IANS) A new fertility treatment using a soya oil-based substance offers hope to women enduring repeated IVF failures by boosting their success rates fivefold.
The research conducted by Care Fertility, in Nottingham in the UK, involved almost 100 women who suffered repeated IVF failures where the embryo had not implanted in the womb.
Of the group, 50 women were given intravenous infusions of Intralipid, a soya oil-based substance, and 46 similar women were not, the Telegraph reports.
Intralipid is used to feed patients artificially through a tube into a blood vessel in cases where they cannot eat or had suffered severe injury or surgery that prevents them from eating normally.
The women were aged around 37 and had undergone an average of six failed cycles of IVF.
Pregnancies were achieved in 50 percent of women who received Intralipid compared with less than nine percent of those who were not given.
There were two miscarriages among the women who received Intralipid, the equivalent to eight percent compared with seven miscarriages or 64 percent in those who did not receive it.
George Ndukwe, medical director at Care Nottingham, said: ‘Every day I see women who have endured numerous IVF cycles all with the same negative outcome and no baby.’
Ndukwe will present these findings at the British Fertility Society meeting in Dublin Jan 6.
